Trial ID: | L0716 |
Source ID: | CTRI/2019/12/022339
|
Associated Drug: |
Saroglitazar Magnesium
|
Title: |
An Investigator initiated prospective, four arms randomized comparative study of efficacy and safety of Saroglitazar, Vitamin E and Life style modification in patients with Non alcoholic fatty liver disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH).
|
Acronym: |
--
|
Status: |
Not Recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
|
Interventions: |
Intervention1: Saroglitazar Magnesium: Patients randomly assigned to this group will receive Saroglitazar Magnesium 4 mg tablet orally once daily for 24 weeks.<br>Intervention2: Vitamin E: Patients randomly assigned to this group will receive Vitamin E or
|
Outcome Measures: |
1. Change in NAFLD fibrosis score at 8week, 16week and 24week. <br/ ><br>2. Compare the overall efficacy of patients with NAFLD/ NASH treated with Saroglitazar magnesium, vitamin E and Saroglitazar magnesium with Vitamin E and Life style modifications alone. <br/ ><br>3. Determine the safety profile of these regimens in those patients.Timepoint: 2 month, 4 month, 6 month1. Serum alanine aminotransferase (ALT) & aspartate aminotransferase (AST) level. <br/ ><br>2. Serum triglycerides (TG) level, high-density lipoprotein (HDL), low density lipoprotein (LDL) & fasting plasma glucose (FPG)/glycosylated haemoglobin (HbA1c). <br/ ><br>3. Liver Biopsy at 24week in selected patients.Timepoint: 2 month, 4 month, 6 month
|
Sponsor/Collaborators: |
Asian Institute of Gastroenterology
|
Gender: |
--
|
Age: |
nannan
|
Phases: |
Phase 3/Phase 4
|
Enrollment: |
200
|
Study Type: |
Interventional
|
Study Designs: |
Randomized, Parallel Group, Multiple Arm Trial<br> Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
|
Start Date: |
12/12/2019
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
24 November 2021
|
Locations: |
India
|
URL: |
http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=37575
|